njundu jatta, johnson stanslas, audrey chee hui yong, wen chung ho, wan syazween lyana wan ahmad kammal, eng wee chua, kang nien how. (2023). whole blood hydroxychloroquine: does genetic polymorphism of cytochrome p450 enzymes have a role?. - clinical and experimental medicine. 4141-4152. |
poh kuan wong, nurul nadia mohamad zamberi, saiful effendi syafruddin, fook choe cheah, norazrina azmi, jia xian law, eng wee chua. (2023). the promises and pitfalls of crispr-mediated base editing in stem cells. - crispr journal. 196-215. |
muhammad asyaari bin zakaria, nor fadilah rajab, eng wee chua, siti fathiah masre. (2023). extracellular matrix dysregulation in lung squamous cell carcinoma (lusc) in vivo: a rna sequencing analysis. - malaysian journal of medicine and health sciences. 4. |
amnani aminuddin, pei yuen ng, eng wee chua. (2022). mitochondrial dna sequences and transcriptomic profiles for elucidating the genetic underpinnings of cisplatin responsiveness in oral squamous cell carcinoma. - bmc genomic data. 1-4. |
sheng zhang lim, raja affendi raja adli, suzana makpol & eng wee chua. (2022). therapeutic monitoring of thiopurine metabolites: validation of an hplc method and preliminary findings from a small cohort of malaysian patients with inflammatory bowel disease. - sains malaysiana. 1847-1859. |
muhammad asyaari zakaria, jazli aziz, nor fadilah rajab, eng wee chua and siti fathiah masre. (2022). tissue rigidity increased during carcinogenesis of ntcu-induced lung squamous cell carcinoma in vivo. - biomedicines. 1-16. |
lishantini pearanpan,fariza juliana nordin,ee ling siew ,endang kumolosasi,ezanee azlina mohamad hanif,siti fathiah masre,eng wee chua,hong sheng cheng,nor fadilah rajab. (2022). a cell-based systematic review on the role of annexin a1 in triple-negative breast cancers. - internation journal of molecular sciences. 1-16. |
muhammad asyaari zakaria, may chee kiew, nor fadilah rajab, eng wee chua, and siti fathiah masre. (2022). rigid tissue increases cytoplasmic pyap expression in pre-malignant stage of lung squamous cell carcinoma (scc) in vivo. - current issues in molecular biology. 4528-4539. |
amnani aminuddin, pei yuen ng, suzana makpol, chee-onn leong, eng wee chua. (2022). rapid changes in mitochondrial dna may participate in the development of cisplatin-resistant oral squamous cell carcinomas. - malaysian journal of medicine and health sciences. 20. |
harsheni karunanathie, ping siu kee, shiow fern ng, martin a. kennedy, eng wee chua. (2022). pcr enhancers: types, mechanisms, and applications in long-range pcr. - biochimie. 130-143. |
nontharit voravuth, eng wee chua, tuan mazlelaa tuan mahmood, ming chiang lim, sharifa ezat wan puteh, nik shanita safii, jyh eiin wong, ahmad taufik jamil, jamia azdina jamal, ahmad fuad shamsuddin, adliah mhd ali. (2022). engaging community pharmacists to eliminate inadvertent doping in sports: a study of their knowledge on doping. - plos one. 1-14. |
harsheni karunanathie, eng wee chua. (2022). determining the enhancing effects of pcr additives on long-range pcr. - malaysian journal of medicine and health sciences. 105. |
nuraziemah ahmad, chua eng wee, lam kok wai, noraziah mohamad zin, fazren azmi. (2021). biomimetic amphiphilic chitosan nanoparticles: synthesis, characterization and antimicrobial activity. - carbohydrate polymers. 1-8. |
poh kuan wong, fook choe cheah, saiful effendi syafruddin, m aiman mohtar, norazrina azmi, pei yuen ng, eng wee chua. (2021). crispr gene-editing models geared toward therapy for hereditary and developmental neurological disorders. - frontiers in pediatrics. 1-15. |
amnani aminuddin, pei yuen ng, chee-onn leong, eng wee chua. (2021). author correction: mitochondrial dna alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. - scientific reports. 1-3. |
muhammadasyaari zakaria, nor fadilah rajab, eng wee chua, gayathrithevi selvarajah & siti fathiah masre. (2021). ntcu induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model. - scientific reports. 1-10. |
muhammad asyaari zakaria, nor fadilah rajab, eng wee chua, gayathri thevi selvarajah, siti fathiah masre. (2021). roles of rho associated kinase in lung cancer: review. - international journal of oncology. 185-198. |
muhammad asyaari zakaria, nor fadilah rajab, eng wee chua, gayathri thevi selvarajah, siti fathiah masre. (2020). the roles of tissue rigidity and its underlying mechanisms in promoting tumor growth. - cancer investigation. 445-462. |
muhammad taufik suaidi, poh kuan wong, nurul ain mohd tahir, and eng wee chua. (2020). community pharmacists' knowledge, attitude, and practice in providing self-care recommendations for the management of premenstrual syndrome. - medicina. 1-16. |
amnani aminuddin, pei yuen ng, chee onn leong, eng wee chua. (2020). mitochondrial dna alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. - scientific reports. 1-17. |
simone l. cree, eng wee chua, jennifer crowther, renwick c.j. dobson, martin a. kennedy. (2020). g-quadruplex structures bind to ez-tn5 transposase. - biochimie. 190-197. |
eng wee chua, simon p. harger, martin a. kennedy. (2019). metoclopramide-induced acute dystonic reactions may be associated with the cyp2d6 poor metaboliser status and pregnancy-related hormonal changes. - frontiers in pharmacology. 1-5. |
eng wee chua, chian siang goh. (2019). benchmarking in silico tools for the functional assessment of dna variants using a set of strictly pharmacogenetic variants. - sains malaysiana. 2151-2159. |
sheng zhang lim, eng wee chua. (2018). revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring. - frontiers in pharmacology. . |
simran ds maggo, eng wee chua, paul chin, simone cree, john pearson, matt doogue, martin a kennedy. (2017). a new zealand platform to enable genetic investigation of adverse drug reactions. - new zealand medical journal. 62-69. |
chua eng wee, ng pei yuen. (2016). minion: a novel tool for predicting drug hypersensitivity?. - frontiers in pharmacology. 1-7. |
eng wee chua, simone l. cree, kim n. t. ton, klaus lehnert, phillip shepherd, nuala helsby, martin a. kennedy. (2016). cross-comparison of exome analysis, next-generation sequencing of amplicons, and the iplex adme pgx panel for pharmacogenomic profiling. - frontiers in pharmacology. 1-7. |
eng wee chua, allison l. miller, martin a. kennedy. (2015). choice of pcr microtube can impact on the success of long-range pcrs. - analytical biochemistry. 115-117. |
eng wee chua, simone cree, murray l. barclay, kit doudney, alan aitchison, martin a. kennedy. (2015). exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers. - the pharmacogenomics journal. 414-421. |
endang kumolosasi, gan boon yan and chua eng wee. (2015). efficacy of some combination regimens of oral hypoglycaemic agents in type 2 diabetes mellitus patients. - tropical journal of pharmaceutical research. 1279-1284. |
trent, r.j., cheong, p.l., chua, e.w., kennedy, m.a.. (2013). progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care. - pathology. 45(4):357-370. |
eng wee chua, james foulds, allison l. miller, martin a. kennedy. (2013). novel cyp2d6 and cyp2c19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine. - pharmacogenetics and genomics. 494-497. |
e kumolosasi, wong sin wei, chua eng wee. (2013). the use of thrombolytic agents in acute myocardial infarction (ami) patients. - international journal of pharmacy and pharmaceutical sciences. 5(2):63-67. |
cheang cheng ye, endang kumolosasi* and chua eng wee. (2012). n-acetylcysteine for prevention of iodinated contrast-induced nephropathy in computed tomography angiography procedures in patients with chronic kidney disease. - african journal of pharmacy and pharmacology. 6(3):181-189. |
e.w. chua and m.a. kennedy. (2012). current state and future prospects of direct-to-consumer pharmacogenetics. - frontiers in pharmacology. 3:1-8. |